Inhibrx Biosciences, Inc

This phase 2 trial tests a drug called INBRX-109 in about 206 people with conventional chondrosarcoma that cannot be removed by surgery or has spread. The drug is an antibody designed to kill cancer cells. Half the participants get the drug, half get a placebo. The main goal is t…

This early-phase trial tests a new drug called INBRX-106, given alone or with the immunotherapy Keytruda, in people with advanced solid tumors (like lung, melanoma, head and neck, stomach, kidney, or bladder cancer) that have stopped responding to standard treatments. The study h…

This study tests whether adding an experimental drug (INBRX-106) to a standard immunotherapy (pembrolizumab) works better than the standard drug alone for people with advanced head and neck cancer that has spread or come back. About 410 adults whose tumors have a specific marker …